These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28647208)

  • 1. MAGE-A family is involved in gastric cancer progression and indicates poor prognosis of gastric cancer patients.
    Lian Y; Sang M; Gu L; Liu F; Yin D; Liu S; Huang W; Wu Y; Shan B
    Pathol Res Pract; 2017 Aug; 213(8):943-948. PubMed ID: 28647208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray.
    Sang M; Gu L; Yin D; Liu F; Lian Y; Zhang X; Liu S; Huang W; Wu Y; Shan B
    J Clin Pathol; 2017 Jun; 70(6):533-540. PubMed ID: 27864450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of family A melanoma antigen in human gastric carcinoma.
    Jung EJ; Kim MA; Lee HS; Yang HK; Lee YM; Lee BL; Kim WH
    Anticancer Res; 2005; 25(3B):2105-11. PubMed ID: 16158951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAGE-A family serves as poor prognostic markers and potential therapeutic targets for epithelial ovarian cancer patients: a retrospective clinical study.
    Sang M; Wu X; Fan X; Lian Y; Sang M
    Gynecol Endocrinol; 2017 Jun; 33(6):480-484. PubMed ID: 28277121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of MAGE-A10 and MAGE-A11 in breast cancers and their prognostic significance: a retrospective clinical study.
    Lian Y; Sang M; Ding C; Zhou X; Fan X; Xu Y; Lü W; Shan B
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):519-27. PubMed ID: 22198676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen.
    Futawatari N; Fukuyama T; Yamamura R; Shida A; Takahashi Y; Nishi Y; Ichiki Y; Kobayashi N; Yamazaki H; Watanabe M
    World J Gastroenterol; 2017 Dec; 23(46):8200-8206. PubMed ID: 29290656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
    Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
    Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demethylation of MAGE promoters during gastric cancer progression.
    Honda T; Tamura G; Waki T; Kawata S; Terashima M; Nishizuka S; Motoyama T
    Br J Cancer; 2004 Feb; 90(4):838-43. PubMed ID: 14970862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer.
    Endo M; Kanda M; Sawaki K; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Yamada S; Koike M; Omae K; Kodera Y
    Anticancer Res; 2019 Nov; 39(11):5903-5910. PubMed ID: 31704814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of C/EBP homologous protein (CHOP) in advanced gastric cancer.
    Zhang X; Zhou T; Li W; Zhang T; Che N; Zu G
    Pathol Res Pract; 2018 Aug; 214(8):1105-1109. PubMed ID: 29910063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
    Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
    Xie C; Subhash VV; Datta A; Liem N; Tan SH; Yeo MS; Tan WL; Koh V; Yan FL; Wong FY; Wong WK; So J; Tan IB; Padmanabhan N; Yap CT; Tan P; Goh LK; Yong WP
    Cell Oncol (Dordr); 2016 Apr; 39(2):175-86. PubMed ID: 26868260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
    Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
    Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
    Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
    World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
    Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
    Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer.
    Wang ZW; Yu QY; Xu MJ; Zhou CY; Li JP; Liao XH
    Aging (Albany NY); 2024 Jan; 16(1):285-298. PubMed ID: 38180746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.